Want to join the conversation?
Matt Duncan of Stephens asks whether one should expect mid-teens growth for 2017 or double-digit growth as there is going to be one less week next year. CFO Drew DeFerrari said $DY is not providing guidance out beyond 1Q17 on a qualitative basis. He added that the growth drivers for the next few quarters are not expected to lessen anytime soon.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?